Frost Radar™: Global Endoscopy Market, 2020

Healthcare Frost Radar™: Global Endoscopy Market, 2020

A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines

RELEASE DATE
22-Dec-2020
REGION
Global
Deliverable Type
Frost Radar
Research Code: MFDE-01-00-00-00
SKU: HC03372-GL-MR_25096
Yes
PDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03372-GL-MR_25096

Frost Radar™: Global Endoscopy Market, 2020
Published on: 22-Dec-2020 | SKU: HC03372-GL-MR_25096

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

Globally, the demand for minimally invasive surgeries is trending upward at a quick pace, so consequently the demand for innovative endoscopy devices used in these procedures is anticipated to surge in the mid-to-long term. Moreover, health systems will be forced to clear the backlogs of “elective surgeries” that were postponed due to the COVID-19 pandemic. Specifically, the amount of surgeries involving the gastrointestinal (GI) tract, urology, and gynecology will flood healthcare systems once the world recovers from the pandemic, thus leading to increased use of endoscopy devices. Because minimally invasive surgeries substantially reduce a patient’s time in hospital and minimize post-operative complications, this approach is preferred by both patients and doctors.

The US Food and Drug Administration (FDA) issued safety recommendations to use partially or fully-disposable duodenoscopes; that, in addition to the awareness COVID-19 created about infection prevention have boosted the development of single-use duodenoscopes and endoscopes. The FDA’s recommendation is based on the fact that certain endoscope devices come with complicated designs and hard-to-clean components, which pose contamination risk from one patient to another if not correctly reprocessed and sterilized.

To supply innovative endoscopic technologies, leading market players aim to differentiate themselves with disruptive breakthroughs and distinctive market expansion strategies. Novel endoscope types are gaining increased attention, such as capsule administered, artificial intelligence (AI)-powered, and robotic-assisted. These advancements effectively propel the global endoscopy devices market by setting new standards of care delivery and enhanced patient health outcomes.

Frost & Sullivan’s research indicates that the global endoscopy market, which is currently crowded by traditional rigid and reprocessed endoscopes, will soon experience a major shift toward flexible single-use devices. The technological innovations are expected to introduce major transformation to the market and create new standards of safety, efficiency, cost-effectiveness, and enhanced quality of care.

In a field of more than 70 global industry participants, Frost & Sullivan independently plotted the top 13 companies in this Frost Radar™ analysis. The Frost Radar™ reveals the market positioning of each company using its Growth and Innovation scores as highlighted in the Frost Radar™ methodology. The document presents competitive profiles on each of the companies based on their strengths, opportunities, and market positioning. We discuss strategic market imperatives and the competitive environment that vendors operate in as well as make recommendations for each provider to spur growth.

Author: Suchismita Das

Strategic Imperative

Strategic Imperative (continued)

Growth Environment

Growth Environment (continued)

Frost Radar™: Global Endoscopy Market

Frost Radar™: Competitive Environment

Frost Radar™: Competitive Environment (continued)

Olympus Corporation

Boston Scientific

Karl Storz-Endoskope

Medtronic plc.

Ambu A/S

Fujifilm Healthcare

Smith & Nephew, Inc.

Stryker Corporation

B. Braun

ConMed Corporation

PENTAX Medical

Auris Health

CapsoVision, Inc.

Strategic Insights

Significance of Being on the Frost Radar™

Frost Radar™ Empowers the CEO’s Growth Team

Frost Radar™ Empowers Investors

Frost Radar™ Empowers Customers

Frost Radar™ Empowers the Board of Directors

Frost Radar™: Benchmarking Future Growth Potential

Frost Radar™: Benchmarking Future Growth Potential

Legal Disclaimer

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Growth Index

Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.

  • Market Share (previous 3 years)
    This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years.
  • Revenue Growth (previous 3 years)
    This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™.
  • Growth Pipeline
    This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities.
  • Vision and Strategy
    This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision?
  • Sales and Marketing
    This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.

Innovation Index

Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.

  • INNOVATION SCALABILITY
    This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals.
  • RESEARCH AND DEVELOPMENT
    This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline.
  • PRODUCT PORTFOLIO
    This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue.
  • MEGATRENDS LEVERAGE
    This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline.
  • CUSTOMER ALIGNMENT
    This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.

Significance of Being on the Frost Radar™

Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.

  • GROWTH POTENTIAL
    Your organization has significant future growth potential, which makes it a Company to Action.
  • BEST PRACTICES
    Your organization is well positioned to shape Growth Pipeline™ best practices in your industry.
  • COMPETITIVE INTENSITY
    Your organization is one of the key drivers of competitive intensity in the growth environment.
  • CUSTOMER VALUE
    Your organization has demonstrated the ability to significantly enhance its customer value proposition.
  • PARTNER POTENTIAL
    Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Globally, the demand for minimally invasive surgeries is trending upward at a quick pace, so consequently the demand for innovative endoscopy devices used in these procedures is anticipated to surge in the mid-to-long term. Moreover, health systems will be forced to clear the backlogs of “elective surgeries” that were postponed due to the COVID-19 pandemic. Specifically, the amount of surgeries involving the gastrointestinal (GI) tract, urology, and gynecology will flood healthcare systems once the world recovers from the pandemic, thus leading to increased use of endoscopy devices. Because minimally invasive surgeries substantially reduce a patient’s time in hospital and minimize post-operative complications, this approach is preferred by both patients and doctors. The US Food and Drug Administration (FDA) issued safety recommendations to use partially or fully-disposable duodenoscopes; that, in addition to the awareness COVID-19 created about infection prevention have boosted the development of single-use duodenoscopes and endoscopes. The FDA’s recommendation is based on the fact that certain endoscope devices come with complicated designs and hard-to-clean components, which pose contamination risk from one patient to another if not correctly reprocessed and sterilized. To supply innovative endoscopic technologies, leading market players aim to differentiate themselves with disruptive breakthroughs and distinctive market expansion strategies. Novel endoscope types are gaining increased attention, such as capsule administered, artificial intelligence (AI)-powered, and robotic-assisted. These advancements effectively propel the global endoscopy devices market by setting new standards of care delivery and enhanced patient health outcomes. Frost & Sullivan’s research indicates that the global endoscopy market, which is currently crowded by traditional rigid and reprocessed endoscopes, will soon experience a major shift toward flexible single-use devices. The technological innovations are expected to introduce major transformation to the market and create new standards of safety, efficiency, cost-effectiveness, and enhanced quality of care. In a field of more than 70 global industry participants, Frost & Sullivan independently plotted the top 13 companies in this Frost Radar™ analysis. The Frost Radar™ reveals the market positioning of each company using its Growth and Innovation scores as highlighted in the Frost Radar™ methodology. The document presents competitive profiles on each of the companies based on their strengths, opportunities, and market positioning. We discuss strategic market imperatives and the competitive environment that vendors operate in as well as make recommendations for each provider to spur growth. Author: Suchismita Das
More Information
Deliverable Type Frost Radar
No Index No
Podcast No
Author Suchismita Das
Industries Healthcare
WIP Number MFDE-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9A4B-B1